Rangering i aksjer
#38816
Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in... Redx Pharma Plc, established in the United Kingdom in 2010 and headquartered in Macclesfield, concentrates its efforts on the discovery, early-stage preclinical development, and licensing of innovative small molecule drugs. The company primarily targets significant unmet medical needs in the therapeutic areas of oncology and fibrosis. Within its oncology portfolio, Redx is progressing RXC004, a porcupine inhibitor currently undergoing Phase II clinical evaluation for treating cancers driven by Wnt-ligands. Additionally, it maintains a research collaboration with Jazz Pharmaceuticals plc, aiming to identify and advance new drug candidates for two specific cancer pathways: the Ras/Raf/MAP kinase pathway. For fibrotic conditions, Redx Pharma is developing several compounds, including RXC007, an oral selective ROCK2 inhibitor intended for the treatment of various fibrotic diseases. Its pipeline also features a gastrointestinal-targeted ROCK inhibitor specifically designed to address fibrosis associated with Crohn's disease, along with a discoidin domain receptors (DDRs) inhibitor for a range of fibrotic disorders. Furthermore, the company is developing RXC006, another porcupine inhibitor, focused on combating fibrotic illnesses such as idiopathic pulmonary fibrosis.
Aksjekurs
$0.20410523
Sist synkronisert: 2024-04-30
Handel Redx Pharma Plc (REDX)
Driftsmargin for Redx Pharma Plc (REDX)
Driftsmargin per 2026 TTM: 0.00%
Ifølge Redx Pharma Plc sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 0.00%. Ved slutten av 2026 hadde selskapet en driftsmargin på 0.00%.
Historikk for driftsmargin for Redx Pharma Plc fra 2026 til 2026
Driftsmargin ved slutten av hvert år
| År |
Driftsmargin |
Endre |
|
Ikke nok data for de angitte datoene. |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap |
Driftsmargin |
Forskjell i driftsmargin |
Land |
|
|
38.97% |
-
|
US
|
|
|
28.81% |
-
|
NL
|
|
|
0.00% |
-
|
CH
|
|
|
0.00% |
-
|
KR
|
|
|
31.23% |
-
|
BE
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.
